Novartis Investigative Site

Botucatu, São Paulo 3880-1001

3 studies enrolling now · 5 studies all time

What they study most

Acromegaly, C3 Glomerulopathy, Ectopic ACTH Syndrome, IC-MPGN, Immune-complex-membranoproliferative Glomerulonephritis, Immunoglobulin A Nephropathy (IgAN), Nelson Syndrome, Pancreatic Neoplasm, Pituitary Neoplasm

Studies at this site

• Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN — Recruiting now
• Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN — Recruiting now
• A Study to Assess the Effects of Zigakibart on IgA Nephropathy. — Recruiting now
• Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly — Completed
• Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin — Stopped early